Leukocytoclastic Vasculitis Related to Ustekinumab in a Crohn's Disease Patient: First Case Report and Literature Review. (2nd July 2019)

• Record Type: Journal Article
• Authors: Costa-Moreira, Pedro; Lopes, Susana; Santos, Ana Luísa; Pedrosa, Ana Filipa; Andrade, Patrícia; Portugal, Raquel; Macedo, Guilherme
• Is Part Of: Journal of Crohn's and colitis. Volume 14:Number 2(2020)
• Page Start: 274
• Page End: 276
• Publication Date: 2019-07-02
• Subjects: Leukocytoclastic vasculitis -- Crohn's disease -- ustekinumab; Inflammatory bowel diseases -- Periodicals; 616.344005
• DOI: 10.1093/ecco-jcc/jjz128
• Languages: English
• ISSNs: 1873-9946

Abstract

Abstract: Leukocytoclastic vasculitis is a single-organ, skin-isolated small vessel vasculitis. It can be a side effect of many common drugs, including biological agents. Unlike with other drugs, leukocytoclastic vasculitis induced by biological agents may have a prolonged latency period. We report the first case of ustekinumab-induced leukocytoclastic vasculitis in a patient with inflammatory bowel disease.